Johnson & Johnson reaffirmed earnings outlook for the year 2015. For the period, the company expects sales of $70 billion to $71 billion, and adjusted earnings for the full-year 2015 of $6.15 to $6.20 per share, which excludes special items such as restructuring charges.
Market Closed -
Other stock markets
|
Pre-market 07:29:54 | |||
156.6 USD | +3.69% |
|
156.4 | -0.14% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.10% | 377B | |
+55.35% | 815B | |
+32.36% | 597B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.49% | 247B | |
+14.94% | 228B | |
+16.54% | 180B | |
+4.31% | 170B | |
+2.86% | 126B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Reaffirms Earnings Outlook for the Year 2015